ARK Invest Short & Squeeze - Edition #3
All 6 ETFs positive in 2023 while ARKW ARKF ARKK ARKQ booming with 35%, 27%, 25% & 17% respectively. Risk appetite for the Innovation/Hyper Growth...
Opko Health (OPK US): Diagnostic Business on Solid Grip; Pharmaceutical Business Ready to Take-Off
Opko Health’s pharmaceutical business is set to see couple of product launches in the international markets, while its diagnostic business is on a...
Solvency Risk Short Candidates: Invitae, AMC, 2U Inc., Delek US
This model seeks companies facing dangerously high leverage coupled with negative or declining cash flows. This week we flag: Invitae, AMC, 2U...
Continued Absence Of Breakdowns Is A Positive Sign; Many Bottoms-Up Stock Recommendations
As long as the Russell 2000 index (IWM) is above $208, the Russell Micro Caps index (IWC) is above $134-$135, and the S&P 500 is above 4495, we...
Invitae: An Emerging Genetic Testing Company with Insider and Institutional Buying
Invitae Corp (NVTA US), an emerging genetic testing company, has been a center of investor attention recently after insider and institutional...
No more insights